Envoy Medical (COCH) Operating Income (2021 - 2026)

Envoy Medical has disclosed Operating Income across 6 years of filings, most recently posting -$5.6 million for Q2 2026.

• In Q2 2026, Operating Income fell 9.84% year-over-year to -$5.6 million; the TTM figure through Jun 2026 stood at -$23.6 million (down 19.92% YoY), while the FY2025 annual figure was -$22.3 million, down 15.65% from the prior year.
• Operating Income came in at -$5.6 million for Q2 2026 at Envoy Medical, up from -$6.0 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$901356.0 in Q2 2022 to a low of -$6.7 million in Q4 2023.
• Average Operating Income over 5 years is -$4.4 million, with a median of -$4.9 million recorded in 2024.
• Year-over-year, Operating Income soared 39.86% in 2022 and sank 397.03% in 2023.
• Over 5 years, Operating Income stood at -$2.9 million in 2022, then plunged by 131.35% to -$6.7 million in 2023, then soared by 32.34% to -$4.5 million in 2024, then plunged by 40.36% to -$6.4 million in 2025, then gained by 12.78% to -$5.6 million in 2026.
• Per Business Quant data, the three most recent Operating Income figures were -$5.6 million in Q2 2026, -$6.0 million in Q1 2026, and -$6.4 million in Q4 2025.